Herbal Formulation and Amlodipine in Essential Hypertensio

Not Applicable

• Conditions: Health Condition 1: I10- Essential (primary) hypertension

• Registration Number: CTRI/2022/09/045143
• Lead Sponsor: GURUKUL CAMPUS UAU HARDWAR

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Patients willing to participate in the study.

2)Patients of either sex with age between 18-70 years.

3)Patients having Hypertension between time interval of 6 months to 1 year.

4)Patients suffering from stage 1 Hypertension (SBP140-159mmHg, DBP 90-99mmHg)

5)Patients suffering from Isolated Systolic Hypertension.

Exclusion Criteria

1)Patients not willing to participate in the study.

2)Patients of either sex below 18 years & above 70 years will be excluded from the study.

3)Patients having Hypertension for <6 months and >1 year will be excluded.

4)Patients of stage 2 Hypertension (SBP >160mmHg and DBP >100mmHg)

5)Patients suffering from serious comorbidities like Renal failure, Coronary Artery Disease, taking medication/drug (oral contraceptives, steroids, chronic use of NSAIDs etc�)

6)Alcoholic and/or drug abusers.

7)History of hypersensitivity to the trail drugs or any of its ingredients.

8)Pregnant /lactating woman.

9)Patients who have completed participation in any other clinical trail during the past 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified